
A global real-world study of the vaccine for respiratory syncytial virus (RSV) finds it offers folks aged 60 and over 80% protection against severe illness and/or hospitalization. With U.S. vaccination rates falling, “I encourage older adults to follow CDC guidance and get vaccinated for RSV as we enter this year’s and every year’s respiratory disease… read on > read on >